Synthetic hair implants offer visible coverage immediately, without harvesting a donor area. Their mechanism is very different from transplantation: they place artificial fibres into the scalp, without a living follicle capable of producing hair.
That distinction explains their maintenance requirements and some of their risks. In the United States, prosthetic hair fibres have been listed among FDA-banned devices since 3 June 1983. The International Society of Hair Restoration Surgery, or ISHRS, adopted a statement aligning with that position in 2021. Here is what to understand before comparing your options. FDA, n.d.; ISHRS, 2021
Header image: AI-generated illustration.
The word “implant” is sometimes used informally for an ordinary hair transplant. Ask exactly what would be placed in your skin.
| Procedure or product | Where is it placed? |
|---|---|
| Synthetic fibre implantation | Anchored beneath the scalp skin |
| Autologous hair transplantation | From donor to recipient area |
| Wig or hair system | Worn externally |
A wig made with synthetic hair therefore does not carry the same risks as a fibre inserted beneath the skin. Camouflage powders or fibres applied to existing hairs are not implants either.
Devices described in the medical literature may have a knot at one end to anchor the fibre. They provide length and colour during the procedure, but do not become follicles. A fibre that breaks or falls out cannot regrow by itself. Näslund-Koch et al., 2020
Their appeal is understandable when hair loss is extensive or you want to avoid waiting months for growth. However, leaving material passing through the skin requires ongoing monitoring and can cause complications. “Biocompatible” does not mean “risk-free”.
The FDA cites serious infections and injuries, as well as misleading claims about benefits and safety. The ISHRS officially shares its position. This establishes an important professional concern; it does not tell us what proportion of surgeons offer or reject the procedure. FDA, n.d.; ISHRS, 2021
The US ban should not be presented as a worldwide rule. A device’s status depends on the country and the particular product. Certification mentioned in an older study does not establish its current status elsewhere or guarantee its safety for an individual patient.
Redness, itching, pain, spots or discharge can develop around the fibres. Some problems respond to medical treatment; others require removal. Inflammation can also occur without bacteria being identified.
Two cases published in 2020 described painful nodules and discharge after implantation. In one patient, a biopsy showed a granulomatous foreign-body reaction. In the other, symptoms resolved after all fibres were extracted, following unsuccessful treatment beforehand. These cases demonstrate possible complications, without measuring how frequently they occur across everyone receiving implants. Näslund-Koch et al., 2020
A granuloma is an organised inflammatory reaction around material perceived as foreign. It does not mean that everyone will inevitably reject every fibre. Tolerance varies, and an initially satisfactory result cannot exclude a later problem.
Persistent inflammation or infection can damage the skin. If a transplant of your own hair is subsequently considered, the scalp needs reassessment. Removing fibres does not guarantee that the skin returns to its original condition or that transplantation can take place immediately.
If you already have implanted fibres and develop persistent pain, nodules, pus or a wound that will not heal, seek medical advice. Tell the clinician what was implanted and when. Do not attempt to extract fibres yourself or keep covering up symptoms with products bought without advice.
Studies differ in the fibres used, patient selection and length of follow-up. An isolated percentage cannot describe your personal risk.
In a prospective open study published in 2018, 213 people were enrolled, but 194 completed two years of follow-up and were analysed. Eighteen of those 194 had adverse events, giving the reported figure of 9.27%; four also needed some fibres removed. Three people who reacted to the preliminary test implants were among those excluded, along with withdrawals and people lost to follow-up. The published rate therefore does not capture every event among all the original participants. Said et al., 2018
The study also reported cosmetic improvements in selected patients receiving regular care and monitoring. It was not a randomised comparison with transplantation using patients’ own follicles. Its findings cannot establish the absence of later complications or equivalent safety between the two procedures.
Equally, a published severe case cannot establish an overall complication rate. A useful assessment considers the benefits reported alongside exclusions, follow-up duration and limitations of the research methods.
Implanted fibres can be lost over time and may need replacement. Reported rates vary between series; presenting one fixed annual percentage as inevitable for everyone would be misleading. Maintaining the original appearance can mean further appointments, scalp care and additional costs.
Before deciding, ask for a quote separating the initial procedure, check-ups, replacement sessions and arrangements for complications or removal. Ask who could examine you near home if the clinic is abroad. A price per fibre does not explain the cost of the whole process.
Autologous transplantation moves living follicles. It avoids leaving artificial fibres in the scalp, but it is still surgery with risks and limitations. These include infection, bleeding, scars, poor graft growth and an appearance different from what you expected. Hair surrounding the transplant can continue to thin. NHS, 2023
You also need a suitable hair transplant donor area. A limited reserve does not become adequate because synthetic implants carry risks. In some cases, transplantation cannot achieve the desired coverage; reducing the goal or choosing a different approach may make more sense.
The diagnosis matters too. Temporary shedding or active disease cannot be approached in the same way as stable pattern hair loss. Medical treatment may be discussed according to the cause, including its likely benefits, side effects and monitoring. An external hair system remains a separate way to obtain coverage without inserting fibres beneath the skin.
Body Expert is a medical tourism agency that supports patients receiving care through partner clinics. For a hair transplant in Turkey, assessment considers the cause of hair loss, donor resources, scalp condition and your coverage goals.
If you have already had fibres implanted, disclose this at the first enquiry and keep any documents identifying the product. The priority is to assess scalp health and whether further surgery would be appropriate. A graft count and timetable should follow that assessment rather than a promise of an immediate cosmetic result.
International Society of Hair Restoration Surgery. (2021, December 11). ISHRS position statement on prosthetic hair fibers. https://ishrs.org/prosthetic-hair-fibers/
Näslund-Koch, C., Thyssen, J. P., Zachariae, C., Nielsen, S. L., & Skov, L. (2020). Side effects after artificial hair implants: 2 case reports. JAAD Case Reports, 6(8), 740–742. https://doi.org/10.1016/j.jdcr.2020.06.004
NHS. (2023, September 29). Hair transplant. https://www.nhs.uk/tests-and-treatments/cosmetic-procedures/cosmetic-surgery/hair-transplant/
Said, A. A. H. R., Albzour, B. M., Santiago, M., Agrawal, M., Rovesti, M., Satolli, F., Wollina, U., Tchernev, G., Lotti, J., & Lotti, T. (2018). Automatic artificial hair implant: Safety and efficacy in androgenetic alopecia. A prospective study with a highly biocompatible fiber. Open Access Macedonian Journal of Medical Sciences, 6(1), 38–42. https://doi.org/10.3889/oamjms.2018.052
U.S. Food and Drug Administration. (n.d.). Medical device bans. https://www.fda.gov/medical-devices/medical-device-safety/medical-device-bans